Evaluating patients with persistent chest pain and no obstructive coronary artery disease

JAMA

Volumn 302, Issue 6, 2009, Pages 622-623

  Beltrame, John F ^a   Ganz, Peter ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIBEFRADIL; CARDIOVASCULAR AGENT; VASODILATOR AGENT;

ANGIOCARDIOGRAPHY; CLINICAL FEATURE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; HUMAN; LETTER; MEDICAL PRACTICE; MICROANGIOPATHY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; THORAX PAIN; ANGINA PECTORIS; ANIMAL; BLOOD FLOW VELOCITY; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; NOTE; RANDOMIZED CONTROLLED TRIAL; REST; SYNDROME X;

ANGINA PECTORIS; ANIMALS; BLOOD FLOW VELOCITY; CARDIOVASCULAR AGENTS; CHEST PAIN; CORONARY CIRCULATION; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MIBEFRADIL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REST; VASODILATOR AGENTS; MICROVASCULAR ANGINA;

EID: 68849093395     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1096     Document Type: Letter

References (5)

1. Phan A, Shufelt C, Merz CN. Persistent chest pain and no obstructive coronary artery disease. JAMA. 2009;301(14):1468-1474.
2. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon: a new coronary microvascular disorder. Cardiology. 2002;97(4):197-202.
3. Leone MC, Gori T, Fineschi M. The coronary slow flow phenomenon: a new cardiac "Y" syndrome? Clin Hemorheol Microcirc. 2008;39(1-4):185-190.
4. Beltrame JF, Turner SP, Leslie SL, Solomon P, Freedman SB, Horowitz JD. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol. 2004;44(1):57-62.
5. Ball CJ, Wilson DP, Turner SP, Saint DA, Beltrame JF. Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade. Hypertension. 2009;53(4):654-660.